Skip to main content
SpringerLink
Log in
Book cover

Positron Emission Tomography pp 107–124Cite as

PET and PET/CT Imaging in Head and Neck Cancer

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: A global perspective on epidemiology and prognosis. Anticancer Res 1998;18:4779–4786.

    PubMed  CAS  Google Scholar 

  2. Kraus DH, Pfister DG, Harrison LB, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngol Head Neck Surg 1994;111:31–37.

    PubMed  CAS  Google Scholar 

  3. Spaulding MB, Fischer SG, Wolf GT. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. J Clin Oncol 1994;12:1592–1599.

    PubMed  CAS  Google Scholar 

  4. Kacker A, Wolden S, Pfister DG, Kraus DH. Cancer of the larynx. In: Myers EN, Suen JY, Myers JN, Hanna EYN, editors. Cancer of the Head and Neck, 4th ed. Philadelphia: Saunders, 2003:333–377.

    Google Scholar 

  5. Myers EN, Suen JY, Myers JN, Hanna EYN, editors. Cancer of the Head and Neck, 4th ed. Philadelphia: Saunders, 2003.

    Google Scholar 

  6. Greene, FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC Cancer Staging Handbook, 6th ed. New York: Springer-Verlag, 2002:27–87.

    Google Scholar 

  7. Harnsberger HR. Handbook of Head and Neck Imaging, 2nd ed. St. Louis: Mosby, 1995.

    Google Scholar 

  8. Gavilán J, Herranz-Gonzales JJ, Lentsch EJ. Cancer of the neck. In: Myers EN, Suen JY, Myers JN, Hanna EYN, editors. Cancer of the Head and Neck, 4th ed. Philadelphia: Saunders, 2003:407–430.

    Google Scholar 

  9. Warburg O. The Metabolism of Tumors. London: Constable, 1930.

    Google Scholar 

  10. Geets X, Daisne JF, Gregoire V, Hamoir M, Lonneux M. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol 2004;71:267–273.

    Article  PubMed  CAS  Google Scholar 

  11. Cobben DC, van der Laan BF, Maas B, Vaalburg W, Suurmeijer AJ, Hoekstra HJ, et al. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET. J Nucl Med 2004; 45:226–231.

    PubMed  Google Scholar 

  12. Chesnay E, Babin E, Constans JM, Agostini D, Bequignon A, Regeasse A, et al. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol 2004;71:267–273.

    Article  CAS  Google Scholar 

  13. De Boer JR, Pruim J, Burlage F, Krikke A, Tiebosch AT, Albers FW, et al. Therapy evaluation of laryngeal carcinomas by tyrosine-pet. Head Neck 2003;25:634–644.

    Article  PubMed  Google Scholar 

  14. Ninomiya H, Oriuchi N, Kahn N, Higuchi T, Endo K, Takahashi K, et al. Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C] choline PET: comparative study with 2-[18F] fluoro-2-deoxy-D-glucose (FDG) PET. Ann Nucl Med 2004;18:29–34.

    Article  PubMed  CAS  Google Scholar 

  15. Khan N, Oriuchi N, Ninomiya H, Higuchi T, Kamada H, Endo K. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET. Ann Nucl Med 2004;18:409–417.

    PubMed  Google Scholar 

  16. Torizuka T, Zasadny KR, Wahl RL. Diabetes decreases FDG accumulation in primary lung cancer. Clin Posit Imaging 1999;2:281–287.

    Article  Google Scholar 

  17. Lowe VJ, Delong DM, Hoffman JM, Patz EF, Coleman RE. Dynamic FDG-PET imaging of focal pulmonary abnormalities to identify optimum time for imaging. J Nucl Med 1995;36:883–887.

    PubMed  CAS  Google Scholar 

  18. Boerner AR, Weckesser M, Herzog H, Schmitz T, Audretsch W, Nitz U, et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 1999;26:226–230.

    Article  PubMed  CAS  Google Scholar 

  19. Thie JA, Hubner KF, Smith GT. Optimizing imaging time for improved performance in oncology PET studies. Mol Imaging Biol 2002;4:238–244.

    Article  PubMed  Google Scholar 

  20. Brink I, Klenzner T, Krause T, Mix M, Ross UH, Moser E, Nitzsche EU. Lymph node staging in extracranial head and neck cancer with FDG PET: appropriate uptake period and size-dependence of the results. Nuklearmedizin 2002;41:108–113.

    PubMed  CAS  Google Scholar 

  21. Ma SY, See LC, Lai CH, Chou HH, Tsai CS, Ng KK, et al. Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 2003;44:1775–1783.

    PubMed  Google Scholar 

  22. Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, Fukuda H. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590–595.

    Article  PubMed  Google Scholar 

  23. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65–72.

    PubMed  Google Scholar 

  24. Hanna EY, Suen JY. Malignant tumors of the salivary glands. In: Myers EN, Suen JY, Myers JN, Hanna EYN, editors. Cancer of the Head and Neck, 4th ed. Philadelphia: Saunders, 2003:475–510.

    Google Scholar 

  25. Bogsrud TV, Karantanis D, Nahan MA, Mullan BP, Kasperbaur J, Strome S, et al. Focal high uptake in the thyroid gland as an incidental finding in 18F-FDG PET. Thyroid 2004;14:760 (abstract).

    Google Scholar 

  26. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery (St. Louis) 2001;130:941–946.

    Article  PubMed  CAS  Google Scholar 

  27. Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88:4100–4104.

    Article  PubMed  CAS  Google Scholar 

  28. Bocca E, Calearo C, Marullo T, DeVincentis I, Motta G, Ottaviani A. Occult metastases in cancer of the larynx and their relationship to clinical and histological aspects of the primary tumor: a four year multicentric research. Laryngoscope 1984;94:1086–1090.

    PubMed  CAS  Google Scholar 

  29. Shuller DE, McGuirt WF, McCabe BF, Young D. The prognostic significance of metastatic cervical lymph nodes. Laryngoscope 1980;90:557–570.

    Google Scholar 

  30. Fukui MB, Curtin HD, Weissman JL. Radiological evaluation of cancer of the head and neck. In: Myers EN, Suen JY, Myers JN, Hanna EYN, editors. Cancer of the Head and Neck, 4th ed. Philadelphia: Saunders, 2003:67–100.

    Google Scholar 

  31. Senchenkov A, Staren ED. Ultrasound in head and neck surgery: thyroid, parathyroid, and cervical lymph nodes. Surg Clin N Am 2004;84:973–1000.

    Article  PubMed  Google Scholar 

  32. Al-Sarraf M, Hussein M. Head and neck cancer: present status and future prospects of adjuvant chemotherapy. Cancer Invest 1995;13:41–53.

    PubMed  CAS  Google Scholar 

  33. Chong VFH, Fan Y-F. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology 1997;202:463–470.

    PubMed  CAS  Google Scholar 

  34. Laubenbacher C, Saumweber D, Wagner MC, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747–1757.

    PubMed  CAS  Google Scholar 

  35. Wong WL, Chevretton EB, McGurk M, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol Appl Sci 1997;22:209–214.

    Article  CAS  Google Scholar 

  36. Rege S, Safa AA, Chaiken L, Hoh C, Juillard G, Withers HR. Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. Am J Clin Oncol 2000;23:164–169.

    Article  PubMed  CAS  Google Scholar 

  37. Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 2003;30:63–71.

    Article  PubMed  CAS  Google Scholar 

  38. Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standarized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 2004;59:1272–1273.

    Article  CAS  Google Scholar 

  39. Kole AC, Nieweg OE, Pruim J, et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer (Phila) 1998;82:1160–1166.

    Article  PubMed  CAS  Google Scholar 

  40. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofacial Surg 1997;26:112–115.

    Article  CAS  Google Scholar 

  41. Assar OS, Fischbein NJ, Caputo GR, Kaplan MJ, Price DC, Singer MI, et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999;210:177–181.

    Google Scholar 

  42. Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumors (UPT). Eur J Cancer 1999;35:1076–1082.

    Article  PubMed  CAS  Google Scholar 

  43. Safa AA, Tran LM, Rege S, et al. The role of positron emission tomography in occult primary head and neck cancers. Cancer J Sci Am 1999;5:214–218.

    PubMed  CAS  Google Scholar 

  44. Jungehulsing M, Scheidhauer K, Damm M, et al. 2[F]-Fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000;123:294–301.

    Article  PubMed  CAS  Google Scholar 

  45. Greven KM, Keyes JJ, Williams Dr, McGuirt WF, Joyce Wr. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-Dglucose. Cancer (Phila) 1999;86:114–118.

    Article  PubMed  CAS  Google Scholar 

  46. Johansen J, Eigtved A, Buchwald C, Theilgaard SA, Hansen HS. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 2002;112:2009–2014.

    Article  PubMed  Google Scholar 

  47. Wong WL, Saunders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol) 2003;15:461–466.

    CAS  Google Scholar 

  48. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255–1260.

    Article  PubMed  CAS  Google Scholar 

  49. Benchaou M, Lehmann W, Slosman DO, et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol 1996;116:332–335.

    PubMed  CAS  Google Scholar 

  50. McGuirt WF, Williams DW 3rd, Keyes JW, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995;105:373–375.

    PubMed  CAS  Google Scholar 

  51. Myers LL, Wax MK, Nabi H, Simpson GT, Lamonica D. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope 1998;108:232–236.

    Article  PubMed  CAS  Google Scholar 

  52. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer (Phila) 1994;73:3047–3058.

    Article  PubMed  CAS  Google Scholar 

  53. Kau RJ, Alexiou C, Laubenbacher C, Werner M, Schwaiger M, Arnold W. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F-18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 1999;125:1322–1328.

    PubMed  CAS  Google Scholar 

  54. Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 2002;236:208–217.

    Article  PubMed  Google Scholar 

  55. Bruschini P, Giorgetti A, Bruschini L, Nacci A, Volterrani D, Cosottini M, et al. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT. Acta Otorhinolaryngol Ital 2003;23:446–453.

    PubMed  CAS  Google Scholar 

  56. Wax MK, Myers LL, Gona JM, Husain SS, Nabi HA. The role of positron emission tomography in the evaluation of the N-positive neck. Otolaryngol Head Neck Surg 2003;129:163–167.

    Article  PubMed  Google Scholar 

  57. Myers LL, Wax MK. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 1998;27:342–347.

    PubMed  CAS  Google Scholar 

  58. Schmid DT, Stoeckli SJ, Bandhauer F, Huguenin P, Schmid S, von Schulthess GK, Goerres GW. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 2003;113:888–891.

    Article  PubMed  Google Scholar 

  59. Goerres GW, Schmid DT, Gratz KW, von Schulthess GK, Eyrich GK. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol 2003;39:547–551.

    Article  PubMed  CAS  Google Scholar 

  60. Sigg MB, Steinert H, Gratz K, Hugenin P, Stoeckli S, Eyrich GK. Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities. J Oral Maxillofac Surg 2003;61:1022–1029.

    Article  PubMed  Google Scholar 

  61. Hollenbeak CS, Lowe VJ, Stack BC Jr. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck. Cancer (Phila) 2001;92:2341–2348.

    Article  PubMed  CAS  Google Scholar 

  62. Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn CS. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck 2001;23:1056–1060.

    Article  PubMed  CAS  Google Scholar 

  63. Hautzel H, Muller GH. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997;38:1384–1386.

    PubMed  CAS  Google Scholar 

  64. Marriott CJC, Thorstad W, Akabani G, Brown MT, McLendon RE, Hanson MW, Coleman RE. Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors. J Nucl Med 1998;39:1376–1380.

    PubMed  CAS  Google Scholar 

  65. Rege SD, Chaiken L, Hoh CK, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993;189:807–812.

    PubMed  CAS  Google Scholar 

  66. Lowe VJ, Heber ME, Anscher MS, Coleman RE. Chest Wall FDG Accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma with radiation. Clin Posit Imaging 1998;1:185–191.

    Article  Google Scholar 

  67. Rege SD, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993;189:807–812.

    PubMed  CAS  Google Scholar 

  68. Lowe V, Dunphy F, Varvares M, et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using FDG-PET. Head Neck 1997;19:666–674.

    Article  PubMed  CAS  Google Scholar 

  69. Greven KM, Williams D3, Keyes JW, McGuirt WF, Watson NJ, Case LD. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am 1997;3:353–357.

    PubMed  CAS  Google Scholar 

  70. Yao M, Graham MM, Hoffman HT, Smith RB, Funk GF, Graham SM, et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004;59:1001–1010.

    Article  PubMed  Google Scholar 

  71. Goerres GW, Mosna-Firlejczyk K, Steurer J, von Schulthess GK, Bachmann LM. Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis. Eur J Nucl Med Mol Imaging 2003;30:562–571.

    Article  PubMed  Google Scholar 

  72. Rogers JW, Greven KM, McGuirt WF, Keyes JW Jr, Williams DW III, Watson NE, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004;58:694–697.

    Article  PubMed  Google Scholar 

  73. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135–141.

    PubMed  CAS  Google Scholar 

  74. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205–211.

    PubMed  CAS  Google Scholar 

  75. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999;109 970–975.

    Article  PubMed  CAS  Google Scholar 

  76. Kao CH, ChangLai SP, Chieng PU, Yen RF, Yen TC. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998;16:3550–3555.

    PubMed  CAS  Google Scholar 

  77. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography J Clin Oncol 2000;18: 651–658.

    PubMed  CAS  Google Scholar 

  78. Fischbein NJ, Assar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 1998;19:1189–1196.

    PubMed  CAS  Google Scholar 

  79. Goerres GW, Schmid DT, Bandhauer F, Huguenin PU, von Schulthess GK, Schmid S, Stoeckli SJ. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:105–109; discussion 120–121.

    Article  PubMed  Google Scholar 

  80. Cheon GJ, Chung JK, So Y, Choi JY, Kim BT, Jeong JM, et al. Diagnostic accuracy of F-18 FDG-PET in the assessment of post-therapeutic recurrence of head and neck cancer. Clin Posit Imaging 1999;2:197–204.

    Article  Google Scholar 

  81. Perlow A, Bui C, Shreve P, Sundgren PC, Teknos TN, Mukherji SK. High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract. J Comput Assist Tomogr 2004;28:704–709.

    Article  PubMed  Google Scholar 

  82. Shu-Hang N, Tung-Chieh JC, Sheng-Chieh C, Sheung-Fat K, Hung-Ming W, Chun-Ta L, et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 2004;45:1669–1677.

    Google Scholar 

  83. Kunkel M, Forster GJ, Reichert TE, Jeong JH, Benz P, Bartenstein P, Wagner W, Whiteside TL. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer (Phila) 2003;98:2257–2265.

    Article  PubMed  Google Scholar 

  84. Tipinis SV, Nagarkar VV, Shestakova I, Gaysinskiy V, Entine G, Tornai MP, Stack BC. Feasibility of beta-gamma digital imaging probe for radioguided surgery. IEEE Trans Nuclear Sci 2004;51:110–116.

    Article  Google Scholar 

  85. Manolidis S, Donald PJ, Valk PE, Pounds TR. The use of positron emission tomography in occult and recurrent head and neck cancer. Acta Otolaryngol 1998;Suppl:534.

    Google Scholar 

  86. Keyes JW Jr, Harkness BA, Greven KM, Williams DW III, Watson NE Jr, McGuirt WF. Salivary gland tumors: pretherapy evaluation with PET. Radiology 1994;192:99–102.

    PubMed  Google Scholar 

  87. McGuirt WF, Keyes JW Jr, Greven KM, Williams DW III, Watson NE Jr, Cappellari JO. Preoperative identification of benign versus malignant parotid masses: a comparative study including positron emission tomography. Laryngoscope 1995;105:579–584.

    Article  PubMed  CAS  Google Scholar 

  88. Okamura T, Kawabe J, Koyama K, Ochi H, Yamada R, Sakamoto H, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol Suppl 1998;538:209–213.

    Article  PubMed  CAS  Google Scholar 

  89. Matsuda M, Sakamoto H, Okamura T, Nakai Y, Ohashi Y, Kawabe J, et al. Positron emission tomographic imaging of pleomorphic adenoma in the parotid gland. Acta Otolaryngol Suppl 1998;538:214–220.

    Article  PubMed  CAS  Google Scholar 

  90. Horiuchi M, Yasuda S, Shohtsu A, Ide M. Four cases of Warthin’s tumor of the parotid gland detected with FDG PET. Ann Nucl Med 1998;112:47–50.

    Article  PubMed  CAS  Google Scholar 

  91. Mackie GC, Yarram SG. Pleomorphic adenoma simulating metastatic squamous cell carcinoma on F-18 fluorodeoxyglucose positron emission tomography. Clin Nucl Med 2004;29:743–744.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology Division of Nuclear Medicine, Mayo Clinic, Rochester, MN, USA

    Val J. Lowe MD

  2. Division of Otolaryngology, Head and Neck Surgery, Pennsylvania State University College of Medicine and Milton S. Hershey Medical Center, Hershey, PA, USA

    Brendan C. Stack Jr. MD, FACS

  3. Department of Medical Imaging Division of Nuclear Medicine University Clinic, The Norwegian Radium Hospital, Oslo, Norway

    Trond V. Bogsrud MD

Authors
  1. Val J. Lowe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brendan C. Stack Jr. MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Trond V. Bogsrud MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Northern California PET Imaging Center, Sacramento, CA, USA

    Peter E. Valk MB, BS, FRACP

  2. Positron Emission Tomography, Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA

    Dominique Delbeke MD, PhD (Professor and Director of Nuclear Medicine) (Professor and Director of Nuclear Medicine)

  3. Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia

    Dale L. Bailey PhD (Associate Professor of Medicine) (Associate Professor of Medicine)

  4. Cancer Imaging and Tracer Development Program, The University of Tennessee Medical Center, Knoxville, TN, USA

    David W. Townsend PhD (Director) (Director)

  5. Department of Radiological Sciences, Guy’s and St Thomas’ Clinical PET Centre, Guy’s and St Thomas’ Hospital Trust, London, UK

    Michael N. Maisey BSc, MD, FRCR, FRCP (Professor of Emeritus) (Professor of Emeritus)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Lowe, V.J., Stack, B.C., Bogsrud, T.V. (2006). PET and PET/CT Imaging in Head and Neck Cancer. In: Valk, P.E., Delbeke, D., Bailey, D.L., Townsend, D.W., Maisey, M.N. (eds) Positron Emission Tomography. Springer, London . https://doi.org/10.1007/1-84628-187-3_8

Download citation

  • DOI: https://doi.org/10.1007/1-84628-187-3_8

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-971-5

  • Online ISBN: 978-1-84628-187-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation